← Latest Filings
A
ARCH Venture Partners X, LLC
Open-market buys
4
$25.0M total
Open-market sells
1
$40K total
Tracking since
Oct 2025
Activity timeline
Open-market buy — $1.0M
Aspen Neuroscience, Inc. · Nov 2, 2026
Open-market buy — $18.0M
Aspen Neuroscience, Inc. · Nov 2, 2026
Open-market trades from the last two years.
Holdings as last reported
12,205,379 Common Stock in NMRA
Held indirectly (By ARCH Venture Fund X, L.P.) · as of 2025-10-27
11,886,758 Common Stock in NMRA
Held indirectly (By ARCH Venture Fund X Overage, L.P.) · as of 2025-10-27
Companies touched
Neumora Therapeutics, Inc.
CIK 0001885522
